Clinical Trials Logo

Filter by:
NCT ID: NCT02285933 Completed - Stroke Clinical Trials

Virtual Reality Exercise for Stroke Rehabilitation in Inpatients Who Are Unable to Stand

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the addition of 10 to 12 sessions of sitting balance exercises using virtual reality training will provide additional gains in balance ability and function over standard inpatient rehabilitation in stroke patients.

NCT ID: NCT02285699 Completed - Clinical trials for Obsessive-Compulsive Disorder

The Gut Microbiota in Obsessive-Compulsive Disorder

Start date: November 1, 2014
Phase: N/A
Study type: Interventional

This study will examine the gut microbiota and serum inflammatory markers in patients with Obsessive-Compulsive Disorder vs. healthy controls. Phase II of the study will examine the gut microbiota and cytokine levels following 12-weeks of treatment with Selective Serotonin Reuptake Inhibitors (SSRIs).

NCT ID: NCT02285621 Completed - Scoliosis Clinical Trials

Validation of a New Generation of Optimized Orthoses for Personalized Treatment of Adolescent Idiopathic Scoliosis

Start date: September 2013
Phase: N/A
Study type: Interventional

Adolescent Idiopathic scoliosis affects 3-4% of the Canadian population, of which about 10% will need a brace treatment during pubertal growth spurt. The design is made relatively corsets empirically, hence the relative efficiency of this treatment. Our team has developed innovative methods for design, optimization and computer aided manufacturing-based numerical simulation models customized to each patient, and a system of evaluation and adjustment of corsets. In this project, the investigators will evaluate the effectiveness of this platform customized treatment and demonstrate its clinical application

NCT ID: NCT02285062 Completed - Clinical trials for Lymphoma, Large B-Cell, Diffuse

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

ROBUST
Start date: February 17, 2015
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of lenalidomide, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R2-CHOP) chemotherapy versus placebo, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (placebo-R-CHOP) chemotherapy in patients who have previously untreated ABC type DLBCL.

NCT ID: NCT02284997 Completed - Clinical trials for Meibomian Gland Dysfunction (MGD)

The Effect of an Eyelid Warming Device for the Management of Meibomian Gland Dysfunction

Hummingbird
Start date: November 2014
Phase: N/A
Study type: Interventional

Along the edge of the eyelids, there are glands (meibomian glands) that produce and deliver oils (meibum) onto the tear film. These oils serve to slow down the evaporation of tears. The meibomian glands may become obstructed due to change in meibum quality. When meibum thickens and solidifies, it plugs the gland openings and oils can no longer reach the tear film. The blockage of the glands is the primary cause of meibomian gland dysfunction (MGD), and may result in symptoms of dry eye (burning, stinging, grittiness, etc.). The typical treatment for MGD is a procedure called "warm compresses". It is a combination of applying heat and pressure to the eyelids for approximately 10 minutes to melt the meibum, unplug the gland openings, and allow oils to flow normally onto the tear film once again. One way to apply heat to the eyelids is by using the MGDRx® EyeBag. The EyeBag is microwaved for 30-40 seconds under full power, and is placed over the closed eyes for approximately 10 minutes. The eyes are gently massaged afterwards. The purpose of this study is to determine how effective the EyeBag is at improving MGD and dry eye symptoms.

NCT ID: NCT02284958 Completed - Low Back Pain Clinical Trials

Walking Away From Back Pain, One Step at a Time

Start date: April 2015
Phase: N/A
Study type: Interventional

This study will investigate if a 12-week, individually-tailored walking program, using pedometers will be a more clinically and cost-effective option for the management of chronic low back pain than standardized advice and education.

NCT ID: NCT02284607 Completed - Healthy Volunteer Clinical Trials

A Study of High Dose MHAA4549A in Healthy Volunteers

Start date: November 3, 2014
Phase: Phase 1
Study type: Interventional

This Phase 1, randomized, double-blind, placebo-controlled study will evaluate the safety, tolerability and pharmacokinetics of two, single intravenous (IV) high doses of MHAA4549A as compared to placebo when administered to healthy volunteers.

NCT ID: NCT02284568 Completed - Clinical trials for Primary Progressive Multiple Sclerosis

A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

ARPEGGIO
Start date: January 12, 2015
Phase: Phase 2
Study type: Interventional

This Phase 2 study is intended to serve as a proof of concept for potential treatment with laquinimod in patients with PPMS. The study is also aimed at evaluating 2 doses of laquinimod in this population.

NCT ID: NCT02283762 Completed - Clinical trials for Scleroderma, Systemic

Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis

Start date: January 15, 2015
Phase: Phase 2
Study type: Interventional

To investigate if Riociguat is effective in the treatment of systemic sclerosis

NCT ID: NCT02283723 Completed - Aging Clinical Trials

A Randomized Controlled Trial Using the Health TAPESTRY Approach to Care for Older Adults

HealthTAPESTRY
Start date: December 2014
Phase: N/A
Study type: Interventional

Health TAPESTRY is a delayed intervention pragmatic randomized control trial promoting interprofessional team collaboration, facilitating connection to the community through system navigation and trained community volunteers, enhancing communication and improving care through the use of technology to better understand and assist older adult patients in achieving their health goals and to enable them to have optimal aging.